Imperial College London

Dr Olivier E. Pardo

Faculty of MedicineDepartment of Surgery & Cancer

Reader in Cancer Cell Signalling
 
 
 
//

Contact

 

+44 (0)20 7594 2814o.pardo Website CV

 
 
//

Location

 

145ICTEM buildingHammersmith Campus

//

Summary

 

Awards

  • Sylvia Lawler Prize 2002, Royal Society of Medicine, Oncology Section, 2002

Membership of Professional Bodies

  • Associate Editor, Oncogene, 2019
  • Fellow, Royal Biological Society, 2017
  • Member, Biochemical Society, 2015
  • Member, British Asociation for Cancer Research, 1999

Industrial Connections

  • AstraZeneca, Roles of FGFR isoforms in Lung cancer
  • ClyzLabs Ltd, Scientific advisor
  • Dundee Cell, Identification of methotrexate resistance mechanisms/biomarkers in gestational trophoblastic tumours
  • Jansen Pharmaceutica NV, Drugable genome-wide study of lung cancer cell local invasion towards the endothelium
  • Johnson & Johnson, RSK4 IN LUNG CANCER METASTASIS – A POTENTIAL THERAPEUTIC TARGET

Fellowships

  • Travel Fellowship, BACR, 2013 - 2013
  • Mid-career fellowship: "Identification of metabolomic changes associated with acquisition of lung cancer resistance to EGFR inhibitors", British Association for Cancer Research, 2011 - 2011
  • Travel Fellowship: “Comparative Phosphoproteomics of FGF-2 and SCF stimulated SCLC cells”., British Association for Cancer Research, 2010 - 2010

Editorial Boards

  • Oncogene, Associate Editor, 2019
  • American journal of cancer science, Associate Editor, 2012
  • American journal of cancer biology, Associate Editor, 2012